Doxorubicin caused severe hyperglycaemia and insulin resistance, mediated by inhibition in AMPk signalling in skeletal muscle

@inproceedings{Jnior2016DoxorubicinCS,
  title={Doxorubicin caused severe hyperglycaemia and insulin resistance, mediated by inhibition in AMPk signalling in skeletal muscle},
  author={Edson Alves de Lima J{\'u}nior and Alex Shimura Yamashita and Gustavo Duarte Pimentel and Lu{\'i}s G O de Sousa and Ronaldo Vagner Thomatieli Santos and Cinara Ludvig Gonçalves and Emilio Luiz Streck and F{\'a}bio Santos de Lira and Jos{\'e} C Rosa Neto},
  booktitle={Journal of cachexia, sarcopenia and muscle},
  year={2016}
}
BACKGROUND Cancer is considered the second leading cause of death in the world, and for the treatment of this disease, pharmacological intervention strategies are frequently based on chemotherapy. Doxorubicin (DOX) is one of the most widely used chemotherapeutic agents in clinical practice for treating a number of solid tumours. The treatment with DOX… CONTINUE READING